Immuneonco Biopharmaceuticals (shanghai) Inc.

This phase 3 study tests whether adding the experimental drug IMM01 (timdarpacept) to standard chemotherapy (azacitidine) helps adults with newly diagnosed chronic myelomonocytic leukemia (CMML). About 170 participants will receive either the combo or a placebo plus azacitidine. …

This early-stage study tests an injectable drug called IMC-001 in 18 people who recently had a heart attack or unstable angina. The goal is to see if it can make fatty plaques in the arteries more stable and less likely to cause future problems. Participants receive either the dr…